Case Study: Complement Activation Related Hypersensitivity Reactions to PEGylated Liposomal Doxorubicin — Experimental and Clinical Evidence, Mechanisms and Approaches to Inhibition
| Publication | Article in Frontiers in Nanobiomedical Research, published February 2016 |
|---|---|
| Authors | Janos Szebeni, Franco Muggia, Yechezkel Barenholz |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…